Wound Management Technologies divests e-health business to focus on wound care
This article was originally published in Clinica
Executive Summary
Wound Management Technologies (WMT) has sold off the Secure eHealth subsidiary it acquired two years ago in order to focus on its lead wound care product, CellerateRx. The two unnamed buyers had helped finance WMT's January 2010 acquisition of Secure eHealth, which specialises in developing software that provides community-based healthcare networks with secure access to electronic information.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.